These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2523155)

  • 41. Rosette formation by peripheral lymphocytes.
    Brain P; Gordon J; Willetts WA
    Clin Exp Immunol; 1970 May; 6(5):681-8. PubMed ID: 5477925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihuman lymphoblast globulin.
    Najarian JS; Simmons RL; Gewurz H; Moberg A; Merkel F; Moore GE
    Fed Proc; 1970; 29(1):197-201. PubMed ID: 4189495
    [No Abstract]   [Full Text] [Related]  

  • 43. Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures.
    Sjöberg O; Andersson J; Möller G
    J Immunol; 1972 Dec; 109(6):1379-85. PubMed ID: 4263894
    [No Abstract]   [Full Text] [Related]  

  • 44. [Standardization of antilymphocyte serum].
    Balner H; Traeger J; van Bekkum DW; Carraz M; Fries D; Plan R; Brochier M; Triau R; Charbonnier C; Cotte J; Durix C; Bonneau M; Veyssere C; Prévot J
    Prog Immunobiol Stand; 1970; 4():214-24. PubMed ID: 4991584
    [No Abstract]   [Full Text] [Related]  

  • 45. In vivo and in vitro correlates of high and moderate potency anti-thymocyte globulin in humans.
    Millington GM; Thomas FT; Thomas JM; Mendez-Picon G; Lower RR; Lee HM
    Surg Forum; 1978; 29():369-71. PubMed ID: 401191
    [No Abstract]   [Full Text] [Related]  

  • 46. Equine anti-human lymphocyte globulin. II. Production and purification of antilymphocyte globulin and its subfractions.
    Wolf RE; Sarles HE; Remmers AR; Fish JC; Mattingly DF; Ritzmann SE
    Tex Rep Biol Med; 1972; 30(4):371-6. PubMed ID: 4676444
    [No Abstract]   [Full Text] [Related]  

  • 47. Activation of human platelets by antibodies to thymocytes and beta 2-microglobulin. I. Qualitative and quantitative aspects of the platelet aggregation induced by HATG and SA beta 2mG.
    Csákó G; Suba EA; Wistar R
    Clin Exp Immunol; 1980 Feb; 39(2):461-9. PubMed ID: 6156042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of antithymocyte serum and globulin without stem cell activity.
    Mosedale B; Smith MA; Courtenay JS
    Transplantation; 1976 Aug; 22(2):122-31. PubMed ID: 788243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Manufacture of antithymocyte globulin (ATGAM) for clinical trials.
    Wechter WJ; Nelson JW; Perper RJ; Parcells AJ; Riebe KW; Evans JS; Satoh PS; Ko H
    Transplantation; 1979 Oct; 28(4):303-7. PubMed ID: 116400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunosuppressive action of antithymocytic serum and specific antibodies on the formation of plaque- and rosette-forming cells].
    Korshunov VM; Pinegin BV
    Patol Fiziol Eksp Ter; 1974; (1):53-7. PubMed ID: 4617852
    [No Abstract]   [Full Text] [Related]  

  • 51. Activation of human platelets by antibodies to thymocytes and beta 2-microglobulin. II. Effect of purified beta 2m on the platelet aggregating and lymphocytotoxic activities of HATG and SA beta 2mG.
    Csákó G; Suba EA; Wistar R
    J Clin Lab Immunol; 1982 Jan; 7(1):33-8. PubMed ID: 6175756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Initial results of clinical compatibility testing of antihuman lymphocyte globulin (AHLG-Dessau)].
    Preussner S; Frick G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(1):31-45. PubMed ID: 4118779
    [No Abstract]   [Full Text] [Related]  

  • 53. Lyt phenotype of T-lymphocytes producing migration inhibitory factor (MIF) in primary murine mixed lymphocyte culture.
    Giovarelli M; Martinotti MG; Cavallo GP; Landolfo S
    Boll Ist Sieroter Milan; 1981 May; 60(2):110-2. PubMed ID: 6458317
    [No Abstract]   [Full Text] [Related]  

  • 54. [Individual reactivity to Imuran, antithymocytic globulin and levamisol].
    Korcáková L; Rovenský J; Pekárek J; Holub M; Kocandrle V
    Cas Lek Cesk; 1982 Sep; 121(38-39):1180-3. PubMed ID: 6982754
    [No Abstract]   [Full Text] [Related]  

  • 55. Researches on the isolation of human antilymphocyte globulin.
    De Barbieri A; Crepaldi L; Tassi CG; Sella A
    Prog Immunobiol Stand; 1970; 4():252-5. PubMed ID: 5482180
    [No Abstract]   [Full Text] [Related]  

  • 56. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H; Dersjant H; van Bekkum DW
    Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666
    [No Abstract]   [Full Text] [Related]  

  • 57. Detection in serum of antilymphocyte-globulin administered in form of eye-drops.
    Leövey A; Fekete B; Szegedi G
    Haematologia (Budap); 1975; 9(1-2):39-41. PubMed ID: 1230398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunofluorescent titration of thymocyte reactive membrane antibodies as a suggested in vitro correlate of the immunosuppressive potency of anti-human thymocyte globulin.
    Ablin RJ; Morrell RM
    Eur Surg Res; 1976; 8(2):140-7. PubMed ID: 821756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glomerular basement membrane--reactive antibody in anti-lymphocyte globulin.
    Wilson CB; Dixon FJ; Fortner JG; Cerilli GJ
    J Clin Invest; 1971 Jul; 50(7):1525-35. PubMed ID: 4996886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human T lymphocytes and myeloid colony forming cells share common antigen.
    Chiao JW; Pahwa RN; Good RA
    Exp Hematol; 1980 Jan; 8(1):6-15. PubMed ID: 6157556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.